Cargando…
A pref-1-controlled non-inflammatory mechanism of insulin resistance
While insulin resistance (IR) is associated with inflammation in white adipose tissue, we report a non-inflammatory adipose mechanism of high fat-induced IR mediated by loss of Pref-1. Pref-1, released from adipose Pref-1+ cells with characteristics of M2 macrophages, endothelial cells or progenitor...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239698/ https://www.ncbi.nlm.nih.gov/pubmed/37283810 http://dx.doi.org/10.1016/j.isci.2023.106923 |
_version_ | 1785053545780740096 |
---|---|
author | Huang, Yiheng Cui, Donghong Chen, Liujun Tong, Haibin Wu, Hong Muller, Grace K. Qi, Yadan Wang, Shuxia Xu, Jinjie Gao, Xiang Fifield, Kathleen E. Wang, Lingyan Xia, Zhengyuan Vanderluit, Jacqueline L. Liu, Suixin Leng, Lin Sun, Guang McGuire, John Young, Lawrence H. Bucala, Richard Qi, Dake |
author_facet | Huang, Yiheng Cui, Donghong Chen, Liujun Tong, Haibin Wu, Hong Muller, Grace K. Qi, Yadan Wang, Shuxia Xu, Jinjie Gao, Xiang Fifield, Kathleen E. Wang, Lingyan Xia, Zhengyuan Vanderluit, Jacqueline L. Liu, Suixin Leng, Lin Sun, Guang McGuire, John Young, Lawrence H. Bucala, Richard Qi, Dake |
author_sort | Huang, Yiheng |
collection | PubMed |
description | While insulin resistance (IR) is associated with inflammation in white adipose tissue, we report a non-inflammatory adipose mechanism of high fat-induced IR mediated by loss of Pref-1. Pref-1, released from adipose Pref-1+ cells with characteristics of M2 macrophages, endothelial cells or progenitors, inhibits MIF release from both Pref-1+ cells and adipocytes by binding with integrin β1 and inhibiting the mobilization of p115. High palmitic acid induces PAR2 expression in Pref-1+ cells, downregulating Pref-1 expression and release in an AMPK-dependent manner. The loss of Pref-1 increases adipose MIF secretion contributing to non-inflammatory IR in obesity. Treatment with Pref-1 blunts the increase in circulating plasma MIF levels and subsequent IR induced by a high palmitic acid diet. Thus, high levels of fatty acids suppress Pref-1 expression and secretion, through increased activation of PAR2, resulting in an increase in MIF secretion and a non-inflammatory adipose mechanism of IR. |
format | Online Article Text |
id | pubmed-10239698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-102396982023-06-06 A pref-1-controlled non-inflammatory mechanism of insulin resistance Huang, Yiheng Cui, Donghong Chen, Liujun Tong, Haibin Wu, Hong Muller, Grace K. Qi, Yadan Wang, Shuxia Xu, Jinjie Gao, Xiang Fifield, Kathleen E. Wang, Lingyan Xia, Zhengyuan Vanderluit, Jacqueline L. Liu, Suixin Leng, Lin Sun, Guang McGuire, John Young, Lawrence H. Bucala, Richard Qi, Dake iScience Article While insulin resistance (IR) is associated with inflammation in white adipose tissue, we report a non-inflammatory adipose mechanism of high fat-induced IR mediated by loss of Pref-1. Pref-1, released from adipose Pref-1+ cells with characteristics of M2 macrophages, endothelial cells or progenitors, inhibits MIF release from both Pref-1+ cells and adipocytes by binding with integrin β1 and inhibiting the mobilization of p115. High palmitic acid induces PAR2 expression in Pref-1+ cells, downregulating Pref-1 expression and release in an AMPK-dependent manner. The loss of Pref-1 increases adipose MIF secretion contributing to non-inflammatory IR in obesity. Treatment with Pref-1 blunts the increase in circulating plasma MIF levels and subsequent IR induced by a high palmitic acid diet. Thus, high levels of fatty acids suppress Pref-1 expression and secretion, through increased activation of PAR2, resulting in an increase in MIF secretion and a non-inflammatory adipose mechanism of IR. Elsevier 2023-05-19 /pmc/articles/PMC10239698/ /pubmed/37283810 http://dx.doi.org/10.1016/j.isci.2023.106923 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Huang, Yiheng Cui, Donghong Chen, Liujun Tong, Haibin Wu, Hong Muller, Grace K. Qi, Yadan Wang, Shuxia Xu, Jinjie Gao, Xiang Fifield, Kathleen E. Wang, Lingyan Xia, Zhengyuan Vanderluit, Jacqueline L. Liu, Suixin Leng, Lin Sun, Guang McGuire, John Young, Lawrence H. Bucala, Richard Qi, Dake A pref-1-controlled non-inflammatory mechanism of insulin resistance |
title | A pref-1-controlled non-inflammatory mechanism of insulin resistance |
title_full | A pref-1-controlled non-inflammatory mechanism of insulin resistance |
title_fullStr | A pref-1-controlled non-inflammatory mechanism of insulin resistance |
title_full_unstemmed | A pref-1-controlled non-inflammatory mechanism of insulin resistance |
title_short | A pref-1-controlled non-inflammatory mechanism of insulin resistance |
title_sort | pref-1-controlled non-inflammatory mechanism of insulin resistance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239698/ https://www.ncbi.nlm.nih.gov/pubmed/37283810 http://dx.doi.org/10.1016/j.isci.2023.106923 |
work_keys_str_mv | AT huangyiheng apref1controllednoninflammatorymechanismofinsulinresistance AT cuidonghong apref1controllednoninflammatorymechanismofinsulinresistance AT chenliujun apref1controllednoninflammatorymechanismofinsulinresistance AT tonghaibin apref1controllednoninflammatorymechanismofinsulinresistance AT wuhong apref1controllednoninflammatorymechanismofinsulinresistance AT mullergracek apref1controllednoninflammatorymechanismofinsulinresistance AT qiyadan apref1controllednoninflammatorymechanismofinsulinresistance AT wangshuxia apref1controllednoninflammatorymechanismofinsulinresistance AT xujinjie apref1controllednoninflammatorymechanismofinsulinresistance AT gaoxiang apref1controllednoninflammatorymechanismofinsulinresistance AT fifieldkathleene apref1controllednoninflammatorymechanismofinsulinresistance AT wanglingyan apref1controllednoninflammatorymechanismofinsulinresistance AT xiazhengyuan apref1controllednoninflammatorymechanismofinsulinresistance AT vanderluitjacquelinel apref1controllednoninflammatorymechanismofinsulinresistance AT liusuixin apref1controllednoninflammatorymechanismofinsulinresistance AT lenglin apref1controllednoninflammatorymechanismofinsulinresistance AT sunguang apref1controllednoninflammatorymechanismofinsulinresistance AT mcguirejohn apref1controllednoninflammatorymechanismofinsulinresistance AT younglawrenceh apref1controllednoninflammatorymechanismofinsulinresistance AT bucalarichard apref1controllednoninflammatorymechanismofinsulinresistance AT qidake apref1controllednoninflammatorymechanismofinsulinresistance AT huangyiheng pref1controllednoninflammatorymechanismofinsulinresistance AT cuidonghong pref1controllednoninflammatorymechanismofinsulinresistance AT chenliujun pref1controllednoninflammatorymechanismofinsulinresistance AT tonghaibin pref1controllednoninflammatorymechanismofinsulinresistance AT wuhong pref1controllednoninflammatorymechanismofinsulinresistance AT mullergracek pref1controllednoninflammatorymechanismofinsulinresistance AT qiyadan pref1controllednoninflammatorymechanismofinsulinresistance AT wangshuxia pref1controllednoninflammatorymechanismofinsulinresistance AT xujinjie pref1controllednoninflammatorymechanismofinsulinresistance AT gaoxiang pref1controllednoninflammatorymechanismofinsulinresistance AT fifieldkathleene pref1controllednoninflammatorymechanismofinsulinresistance AT wanglingyan pref1controllednoninflammatorymechanismofinsulinresistance AT xiazhengyuan pref1controllednoninflammatorymechanismofinsulinresistance AT vanderluitjacquelinel pref1controllednoninflammatorymechanismofinsulinresistance AT liusuixin pref1controllednoninflammatorymechanismofinsulinresistance AT lenglin pref1controllednoninflammatorymechanismofinsulinresistance AT sunguang pref1controllednoninflammatorymechanismofinsulinresistance AT mcguirejohn pref1controllednoninflammatorymechanismofinsulinresistance AT younglawrenceh pref1controllednoninflammatorymechanismofinsulinresistance AT bucalarichard pref1controllednoninflammatorymechanismofinsulinresistance AT qidake pref1controllednoninflammatorymechanismofinsulinresistance |